Nanotechnologys potential to transform RA management extends beyond high-income settings, offering scalable solutions to reduce the global burden of autoimmune diseases
BPC-157 does not need to be injected at the site of injury
Non-persistence to OAC was associated with lower EQ-VAS up to 36 months (observations = 1,713, n = 732, = -5.39, p 75%) of the patients with PSSP reported pain onset within 2 months after stroke
Conclusion: Decline in retinal VD associated with temporal changes in brain lesion volume provides more evidence of remote effects of ischaemic stroke on the retina, suggesting its application as a biomarker for the efficacy of treatment or rehabilitation
Different models can be used for the classification of ACPs, i.e., based on their secondary structure (18), amphipathicity (19), or sources